Balentine LLC’s Dorman Products DORM Stock Holding History

Balentine LLC’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-22	Closed	-$2K	–	759
2019 Q2	$2K	Buy	+22	New	+$1.91K	﹤0.01%	620

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Balentine LLC's DORM Position: Q3 2019 in Review

Balentine LLC sold out of Dorman Products (DORM) in Q3 2019, closing a stake of 22 shares — an estimated $2K sold.

Balentine LLC first reported a position in DORM in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 230 funds tracked by Wall St. Rank hold DORM as of Q3 2019.

Balentine LLC reported no remaining Dorman Products position as of Q3 2019 after selling out during the quarter.
Balentine LLC sold 22 Dorman Products shares in Q3 2019, an estimated $2K.
Balentine LLC first reported a position in Dorman Products in Q2 2019 and held it in 1 quarter.
Balentine LLC's Dorman Products position peaked at $2K in Q2 2019.
230 funds tracked by Wall St. Rank held Dorman Products as of Q3 2019.

Based on Balentine LLC's 13F filing for Q3 2019, filed 15 Nov 2019.